Celanese Corporation Reports First Quarter 2022 Earnings; Raises Full Year 2022 Outlook

Thu, April 28 2022

DALLAS--(BUSINESS WIRE)-- Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported GAAP diluted earnings per share of $4.61 and adjusted earnings per share of $5.54 for the first quarter of 2022. The Company reported record quarterly net sales of $2.5 billion, a 12 percent increase over the previous record set in the fourth quarter of 2021. Net sales growth was driven by sequential volume and price expansion of 12 percent and 1 percent, respectively. Celanese successfully mitigated continued cost inflation as well as sourcing and logistics constraints to deliver first quarter consolidated operating profit of $531 million and adjusted EBIT of $713 million, both records. In February, the Company announced a definitive agreement to acquire a majority of the Mobility & Materials ("M&M") business of DuPont for $11.0 billion, which will establish Celanese as the preeminent global specialty materials company and is expected to drive a doubling of annual free cash flow generation, inclusive of run-rate synergies.

"I thank our teams for delivering record adjusted earnings per share in the first quarter, exceeding our prior record by 10 percent, and for establishing tremendous momentum at the start of 2022," said Lori Ryerkerk, chairman and chief executive officer. "We are squarely focused on continuing this momentum in our business performance and preparing ourselves for the close of the M&M acquisition which will usher in the next phase of shareholder value creation at Celanese."

First Quarter 2022 Financial Highlights:

		Three Months Ended
		March 31, 2022				December 31, 2021				March 31, 2021
		(unaudited)
		(In $ millions, except per share data)
Net Sales
Engineered Materials			910				707				645
Acetate Tow			125				129				119
Acetyl Chain			1,538				1,476				1,056
Intersegment Eliminations			(35	)			(37	)			(22	)
Total			2,538				2,275				1,798
Operating Profit (Loss)
Engineered Materials			124				67				130
Acetate Tow			4				4				16
Acetyl Chain			499				535				251
Other Activities			(96	)			(89	)			(71	)
Total			531				517				326
Net Earnings (Loss)			504				526				323
Adjusted EBIT(1)
Engineered Materials			211				113				160
Acetate Tow			40				38				61
Acetyl Chain			503				536				282
Other Activities			(41	)			(35	)			(21	)
Total			713				652				482
Equity Earnings and Dividend Income, Other Income (Expense)
Engineered Materials			49				30				25
Acetate Tow			36				34				41
Operating EBITDA(1)			813				745				570
Diluted EPS - continuing operations		$	4.61			$	4.83			$	2.83
Diluted EPS - total		$	4.61			$	4.79			$	2.82
Adjusted EPS(1)		$	5.54			$	4.91			$	3.46
Net cash provided by (used in) investing activities			(149	)			(1,286	)			98
Net cash provided by (used in) financing activities			(95	)			(99	)			(371	)
Net cash provided by (used in) operating activities			316				584				116
Free cash flow(1)			175				415				19
______________________________
(1) See "Non-US GAAP Financial Measures" below.

Recent Highlights:

• Announced the signing of a definitive agreement to acquire a majority of the M&M business for $11.0 billion in cash, including a broad portfolio of engineered thermoplastics and elastomers, industry-renowned brands and intellectual property, global production assets, and a world-class organization.

• Completed the restructuring of the Korea Engineering Plastics Co. (KEPCO) joint venture to a manufacturing entity. Celanese will market approximately 70 kt of POM offtake, consistent with its 50 percent ownership stake.

• Lori Ryerkerk was awarded The Chemists' Club Kavaler Award 2022, voted on by chemical industry peers to recognize exceptional performance of innovators and disruptors of the status quo in the sector.

• Elected Rahul Ghai to the Company's Board of Directors in February. Mr. Ghai currently serves as Executive Vice President and Chief Financial Officer of Otis Worldwide Corporation.

• Elected Michael Koenig to the Company's Board of Directors in February. Mr. Koenig serves as Chief Executive Officer and a member of the board of directors of Nobian Industrial Chemicals B.V.

• Received a third investment grade credit rating for the Company as Fitch Ratings assigned a first-time credit rating on Celanese of BBB- with a Stable Outlook.

First Quarter 2022 Business Segment Overview

Engineered Materials

Engineered Materials generated record net sales of $910 million in the first quarter due to a sequential volume increase of 23 percent and price increase of 7 percent. Approximately one-third of the sequential volume increase was delivered by legacy products, excluding Santoprene, as the business produced to meet elevated demand led by automotive. With five consecutive quarters of pricing expansion, Engineered Materials maintained a full pass-through of total cost inflation spanning raw materials, energy, and logistics. First quarter GAAP operating profit of $124 million and adjusted EBIT of $211 million increased over the prior quarter by $57 million and $98 million, respectively. Affiliate earnings contributed an additional $19 million sequentially, due to strong performance of the KEPCO and Infraserv affiliates.

Acetyl Chain

The Acetyl Chain generated record net sales of $1.5 billion in the first quarter due to an 8 percent sequential expansion in volume that offset a 3 percent decline in pricing. Sequential moderation in China acetic acid pricing was largely offset as the business shifted volume to the Western Hemisphere and captured higher pricing downstream in VAM, emulsions, redispersible powders (RDP), and ethylene vinyl acetate (EVA). In the quarter, the Acetyl Chain manufacturing team successfully completed three major turnarounds at the Clear Lake facility in methanol, acetic acid, and VAM. The Acetyl Chain offset production impacts by flexing its global footprint and sourcing from the industry to deliver first quarter GAAP operating profit of $499 million and adjusted EBIT of $503 million at margins of 32 percent and 33 percent, respectively. Across the last four quarters the Acetyl Chain has delivered over $2 billion in GAAP operating profit and adjusted EBIT.

Acetate Tow

Acetate Tow generated net sales of $125 million during the first quarter, which reflected a sequential price increase of 3 percent and a volume decrease of 6 percent. First quarter GAAP operating profit of $4 million and adjusted EBIT of $40 million were consistent with business expectations. Dividends from affiliates in the quarter were $36 million, consistent with the prior quarter.

Cash Flow and Tax

The Company generated operating cash flow of $316 million and free cash flow of $175 million in the first quarter. Capital expenditures in the quarter were $137 million as the Company progressed on several key projects across the Engineered Materials and Acetyl Chain businesses. During the first quarter, Celanese returned $73 million in cash to shareholders via dividends.

The effective U.S. GAAP tax rate was 18 percent for the first quarter compared to 21 percent for the same quarter of 2021. The lower effective tax rate was due to non-recurring impacts of uncertain tax positions mainly due to lending terms related to internal treasury operations in the three months ended March 31, 2021. During the first quarter, the Company decreased the full year adjusted tax rate from 15 percent to 13 percent, primarily due to changes in jurisdictional earnings mix.

Outlook

"Our team continues to demonstrate the capability of our Engineered Materials and Acetyl Chain business models to deliver robust performance despite persistent cost inflation and various external disruptions to our supply chain" said Lori Ryerkerk. "While we have successfully mitigated the vast majority of these disruptions, we are closely monitoring developing challenges including COVID-19 lockdowns across China and worsening reliability of global maritime logistics. As pricing in upstream products within the Acetyl Chain continues to moderate, we expect that strength in downstream Acetyl Chain products as well as continued robust performance in Engineered Materials will drive second quarter adjusted earnings of approximately $4.50 per share. With this strong start to the year, we now expect 2022 adjusted earnings per share to approach our 2021 adjusted earnings per share performance."

A reconciliation of forecasted adjusted earnings per share to U.S. GAAP diluted earnings per share is not available without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains/losses, is not practical. For more information, see "Non-GAAP Financial Measures" below.

The Company's prepared remarks related to the first quarter will be posted on its website at investors.celanese.com under Financial Information/Financial Document Library on April 28, 2022. Information about Non-US GAAP measures is included in a Non-US GAAP Financial Measures and Supplemental Information document posted on our investor relations website under Financial Information/Non-GAAP Financial Measures. See also "Non-GAAP Financial Measures" below.

Celanese Corporation is a global chemical leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our businesses use the full breadth of Celanese's global chemistry, technology and commercial expertise to create value for our customers, employees, shareholders and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 8,500 employees worldwide and had 2021 net sales of $8.5 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com.

Forward-Looking Statements

This release may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; volatility or changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; the length and depth of product and industry business cycles, particularly in the automotive, electrical, mobility, textiles, medical, electronics and construction industries; the extent to which resurgences or variants of COVID-19 may adversely impact the economic environment, market demand, our operations, availability and cost of transportation and materials, the labor supply and pace of economic recovery; the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases; the ability to maintain plant utilization rates and to implement planned capacity additions and expansions as well as facility turnarounds; the ability to reduce or maintain their current levels of production costs and to improve productivity by implementing technological improvements to existing plants; the ability to identify desirable potential acquisition targets and to complete and integrate acquisition or investment transactions consistent with the Company's strategy; the ability to obtain regulatory approval for, and satisfy closing conditions to, the M&M acquisition, the timing of closing thereof, and the ability to realize the anticipated benefits of the transaction; the ability to identify and execute on other attractive investment opportunities towards which to deploy capital; increased price competition and the introduction of competing products by other companies; market acceptance of our products and technology; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation or logistics disruptions, cyber security incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic); other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war (such as the Russia-Ukraine conflict) or terrorist incidents or as a result of weather or natural disasters or other crises including public health crises; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change; potential liability resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate; changes in currency exchange rates and interest rates; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; tax rates and changes thereto; our ability to obtain regulatory approval for, and satisfy closing conditions to, any transactions described herein; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission.

Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

Non-GAAP Financial Measures

Presentation

This document presents the Company's three business segments, Engineered Materials, Acetate Tow and Acetyl Chain.

Use of Non-US GAAP Financial Information

This release uses the following Non-US GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, adjusted earnings per share and free cash flow. These measures are not recognized in accordance with US GAAP and should not be viewed as an alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin is operating margin; for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; and for free cash flow is net cash provided by (used in) operations.

Definitions of Non-US GAAP Financial Measures

• Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8 of our Non-US GAAP Financial Measures and Supplemental Information document). We do not provide reconciliations for adjusted EBIT on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales.

• Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization.

• Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
  
  Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a of our Non-US GAAP Financial Measures and Supplemental Information document summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.

• Free cash flow is a liquidity measure used by the Company and is defined by the Company as cash flow from operations, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our methanol joint venture, Fairway Methanol LLC ("Fairway").

Reconciliation of Non-US GAAP Financial Measures

Reconciliations of the Non-US GAAP financial measures used in this press release to the comparable US GAAP financial measure, together with information about the purposes and uses of Non-US GAAP financial measures, are included in our Non-US GAAP Financial Measures and Supplemental Information document filed as an exhibit to our Current Report on Form 8-K filed with the SEC on or about April 28, 2022 and also available on our website at investors.celanese.com under Financial Information/Financial Document Library.

Results Unaudited

The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

Supplemental Information

Additional information about our prior period performance is included in our Quarterly Reports on Form 10-Q and in our Non-US GAAP Financial Measures and Supplemental Information document.

Consolidated Statements of Operations - Unaudited

		Three Months Ended
		March 31, 2022			December 31, 2021			March 31, 2021
		(In $ millions, except share and per share data)
Net sales		2,538			2,275			1,798
Cost of sales		(1,793	)		(1,554	)		(1,313	)
Gross profit		745			721			485
Selling, general and administrative expenses		(174	)		(170	)		(137	)
Amortization of intangible assets		(11	)		(8	)		(6	)
Research and development expenses		(24	)		(23	)		(20	)
Other (charges) gains, net		(1	)		—			6
Foreign exchange gain (loss), net		(1	)		—			3
Gain (loss) on disposition of businesses and assets, net		(3	)		(3	)		(5	)
Operating profit (loss)		531			517			326
Equity in net earnings (loss) of affiliates		56			36			29
Non-operating pension and other postretirement employee benefit (expense) income		24			(7	)		38
Interest expense		(35	)		(21	)		(25	)
Interest income		1			1			1
Dividend income - equity investments		37			33			42
Other income (expense), net		2			(2	)		(2	)
Earnings (loss) from continuing operations before tax		616			557			409
Income tax (provision) benefit		(112	)		(27	)		(85	)
Earnings (loss) from continuing operations		504			530			324
Earnings (loss) from operation of discontinued operations		—			(3	)		(1	)
Income tax (provision) benefit from discontinued operations		—			(1	)		—
Earnings (loss) from discontinued operations		—			(4	)		(1	)
Net earnings (loss)		504			526			323
Net (earnings) loss attributable to noncontrolling interests		(2	)		(2	)		(1	)
Net earnings (loss) attributable to Celanese Corporation		502			524			322
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations		502			528			323
Earnings (loss) from discontinued operations		—			(4	)		(1	)
Net earnings (loss)		502			524			322
Earnings (loss) per common share - basic
Continuing operations		4.64			4.86			2.85
Discontinued operations		—			(0.04	)		(0.01	)
Net earnings (loss) - basic		4.64			4.82			2.84
Earnings (loss) per common share - diluted
Continuing operations		4.61			4.83			2.83
Discontinued operations		—			(0.04	)		(0.01	)
Net earnings (loss) - diluted		4.61			4.79			2.82
Weighted average shares (in millions)
Basic		108.2			108.6			113.5
Diluted		108.9			109.4			114.0

Consolidated Balance Sheets - Unaudited

		As of March 31, 2022			As of December 31, 2021
		(In $ millions)
ASSETS
Current Assets
Cash and cash equivalents		605			536
Trade receivables - third party and affiliates, net		1,390			1,161
Non-trade receivables, net		523			506
Inventories		1,549			1,524
Marketable securities		9			10
Other assets		124			70
Total current assets		4,200			3,807
Investments in affiliates		847			823
Property, plant and equipment, net		4,188			4,193
Operating lease right-of-use assets		267			236
Deferred income taxes		244			248
Other assets		569			521
Goodwill		1,396			1,412
Intangible assets, net		715			735
Total assets		12,426			11,975
LIABILITIES AND EQUITY
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates		860			791
Trade payables - third party and affiliates		1,169			1,160
Other liabilities		419			473
Income taxes payable		106			81
Total current liabilities		2,554			2,505
Long-term debt, net of unamortized deferred financing costs		3,132			3,176
Deferred income taxes		563			555
Uncertain tax positions		296			280
Benefit obligations		543			558
Operating lease liabilities		223			200
Other liabilities		162			164
Commitments and Contingencies
Stockholders' Equity
Treasury stock, at cost		(5,492	)		(5,492	)
Additional paid-in capital		326			333
Retained earnings		10,106			9,677
Accumulated other comprehensive income (loss), net		(333	)		(329	)
Total Celanese Corporation stockholders' equity		4,607			4,189
Noncontrolling interests		346			348
Total equity		4,953			4,537
Total liabilities and equity		12,426			11,975

Non-US GAAP Financial Measures and Supplemental Information

April 28, 2022

In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis.

Purpose

The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-US GAAP financial measures. This document is updated quarterly.

Presentation

This document presents the Company's three business segments, Engineered Materials, Acetate Tow and Acetyl Chain.

Use of Non-US GAAP Financial Measures

From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with US GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are excluded from the most directly comparable US GAAP measure so calculated and presented. For these purposes, "GAAP" refers to generally accepted accounting principles in the United States.

Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other US GAAP financial measure. These non-GAAP financial measures should be considered within the context of our complete audited and unaudited financial results for the given period, which are available on the Financial Information/Financial Document Library page of our website, investors.celanese.com. The definition and method of calculation of the non-GAAP financial measures used herein may be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive or projections of future results.

Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Financial Information/Financial Document Library page of our website, investors.celanese.com, to the extent practicable, the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.

This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.

Specific Measures Used

This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt is total debt; for free cash flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss) attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity.

Definitions

• Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8). We believe that adjusted EBIT provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of unusual, non-operational or restructuring-related activities that affect comparability. Our management recognizes that adjusted EBIT has inherent limitations because of the excluded items. Adjusted EBIT is one of the measures management uses for planning and budgeting, monitoring and evaluating financial and operating results and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted EBIT on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales. Adjusted EBIT margin has the same uses and limitations as Adjusted EBIT.

• Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization. We believe that Operating EBITDA provides transparent and useful information to investors, analysts and other parties in evaluating our operating performance relative to our peer companies. Operating EBITDA margin is defined by the Company as Operating EBITDA divided by net sales. Operating EBITDA margin has the same uses and limitations as Operating EBITDA.

• Operating profit (loss) attributable to Celanese Corporation is defined by the Company as operating profit (loss), less earnings (loss) attributable to noncontrolling interests ("NCI"). We believe that operating profit (loss) attributable to Celanese Corporation provides transparent and useful information to management, investors, analysts and other parties in evaluating our core operational performance. Operating margin attributable to Celanese Corporation is defined by the Company as operating profit (loss) attributable to Celanese Corporation divided by net sales. Operating margin attributable to Celanese Corporation has the same uses and limitations as Operating profit (loss) attributable to Celanese Corporation.

• Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We believe that adjusted earnings per share provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of the above stated items that affect comparability and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
  
  Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.

• Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operations, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our methanol joint venture, Fairway Methanol LLC ("Fairway"). We believe that free cash flow provides useful information to management, investors, analysts and other parties in evaluating the Company's liquidity and credit quality assessment because it provides an indication of the long-term cash generating ability of our business. Although we use free cash flow as a measure to assess the liquidity generated by our business, the use of free cash flow has important limitations, including that free cash flow does not reflect the cash requirements necessary to service our indebtedness, lease obligations, unconditional purchase obligations or pension and postretirement funding obligations.

• Net debt is defined by the Company as total debt less cash and cash equivalents. We believe that net debt provides useful information to management, investors, analysts and other parties in evaluating changes to the Company's capital structure and credit quality assessment.

• Return on invested capital (adjusted) is defined by the Company as adjusted EBIT, tax effected using the adjusted tax rate, divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity. We believe that return on invested capital (adjusted) provides useful information to management, investors, analysts and other parties in order to assess our income generation from the point of view of our stockholders and creditors who provide us with capital in the form of equity and debt and whether capital invested in the Company yields competitive returns.

Supplemental Information

Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:

• Net sales for each of our business segments and the percentage increase or decrease in net sales attributable to price, volume, currency and other factors for each of our business segments.

• Cash dividends received from our equity investments.

• For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside stockholders' interests are shown as NCI. Beginning in 2014, this includes Fairway for which the Company's ownership percentage is 50%. Amounts referred to as "attributable to Celanese Corporation" are net of any applicable NCI.

Results Unaudited

The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

Table 1 Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited
	Q1 '22			2021			Q4 '21			Q3 '21			Q2 '21			Q1 '21
	(In $ millions)
Net earnings (loss) attributable to Celanese Corporation	502			1,890			524			506			538			322
(Earnings) loss from discontinued operations	—			22			4			13			4			1
Interest income	(1	)		(8	)		(1	)		(2	)		(4	)		(1	)
Interest expense	35			91			21			21			24			25
Refinancing expense	—			9			—			9			—			—
Income tax provision (benefit)	112			330			27			102			116			85
Certain Items attributable to Celanese Corporation (Table 8)	65			139			77			(1	)		13			50
Adjusted EBIT	713			2,473			652			648			691			482
Depreciation and amortization expense(1)	100			362			93			91			90			88
Operating EBITDA	813			2,835			745			739			781			570

	Q1 '22			2021			Q4 '21			Q3 '21			Q2 '21			Q1 '21
	(In $ millions)
Engineered Materials	4			9			4			2			1			2
Acetate Tow	—			—			—			—			—			—
Acetyl Chain	2			—			—			—			—			—
Other Activities(2)	—			—			—			—			—			—
Accelerated depreciation and amortization expense	6			9			4			2			1			2
Depreciation and amortization expense(1)	100			362			93			91			90			88
Total depreciation and amortization expense	106			371			97			93			91			90

______________________________
(1)	Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above.
(2)	Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited
	Q1 '22						2021						Q4 '21						Q3 '21						Q2 '21						Q1 '21
	(In $ millions, except percentages)
Operating Profit (Loss) / Operating Margin
Engineered Materials	124			13.6	%		411			15.1	%		67			9.5	%		91			13.3	%		123			18.0	%		130			20.2	%
Acetate Tow	4			3.2	%		56			10.9	%		4			3.1	%		12			9.4	%		24			17.4	%		16			13.4	%
Acetyl Chain(1)	499			32.4	%		1,819			33.5	%		535			36.2	%		517			34.7	%		516			36.6	%		251			23.8	%
Other Activities(2)	(96	)					(340	)					(89	)					(84	)					(96	)					(71	)
Total	531			20.9	%		1,946			22.8	%		517			22.7	%		536			23.7	%		567			25.8	%		326			18.1	%
Less: Net Earnings (Loss) Attributable to NCI(1)	2						6						2						1						2						1
Operating Profit (Loss) Attributable to Celanese Corporation	529			20.8	%		1,940			22.7	%		515			22.6	%		535			23.6	%		565			25.7	%		325			18.1	%
Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation
Engineered Materials	124			13.6	%		411			15.1	%		67			9.5	%		91			13.3	%		123			18.0	%		130			20.2	%
Acetate Tow	4			3.2	%		56			10.9	%		4			3.1	%		12			9.4	%		24			17.4	%		16			13.4	%
Acetyl Chain(1)	497			32.3	%		1,813			33.4	%		533			36.1	%		516			34.7	%		514			36.5	%		250			23.7	%
Other Activities(2)	(96	)					(340	)					(89	)					(84	)					(96	)					(71	)
Total	529			20.8	%		1,940			22.7	%		515			22.6	%		535			23.6	%		565			25.7	%		325			18.1	%
Equity Earnings and Dividend Income, Other Income (Expense) Attributable to Celanese Corporation
Engineered Materials	49						127						30						40	(3)					32						25
Acetate Tow	36						146						34						34						37						41
Acetyl Chain	4						8						2						2						2						2
Other Activities(2)	6						7						1						1						4						1
Total	95						288						67						77						75						69
Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation
Engineered Materials	—						—						—						—						—						—
Acetate Tow	—						—						—						—						—						—
Acetyl Chain	—						—						—						—						—						—
Other Activities(2)	24						106						(7	)					37						38						38
Total	24						106						(7	)					37						38						38
Certain Items Attributable to Celanese Corporation (Table 8)
Engineered Materials	38						33						16						6						6						5
Acetate Tow	—						5						—						—						1						4
Acetyl Chain	2						28						1						(1	)					(2	)					30
Other Activities(2)	25						73						60						(6	)					8						11
Total	65						139						77						(1	)					13						50

___________________________
(1)	Net earnings (loss) attributable to NCI is included within the Acetyl Chain segment.
(2)	Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
(3)	Includes $39 million of Equity in net earnings (loss) of affiliates and $1 million of Other income.

Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.)
	Q1 '22						2021						Q4 '21						Q3 '21						Q2 '21						Q1 '21
	(In $ millions, except percentages)
Adjusted EBIT / Adjusted EBIT Margin
Engineered Materials	211			23.2	%		571			21.0	%		113			16.0	%		137			20.0	%		161			23.6	%		160			24.8	%
Acetate Tow	40			32.0	%		207			40.3	%		38			29.5	%		46			35.9	%		62			44.9	%		61			51.3	%
Acetyl Chain	503			32.7	%		1,849			34.1	%		536			36.3	%		517			34.7	%		514			36.5	%		282			26.7	%
Other Activities(2)	(41	)					(154	)					(35	)					(52	)					(46	)					(21	)
Total	713			28.1	%		2,473			29.0	%		652			28.7	%		648			28.6	%		691			31.4	%		482			26.8	%
Depreciation and Amortization Expense(1)
Engineered Materials	42						135						35						33						34						33
Acetate Tow	11						39						10						10						9						10
Acetyl Chain	43						171						43						44						43						41
Other Activities(2)	4						17						5						4						4						4
Total	100						362						93						91						90						88
Operating EBITDA / Operating EBITDA Margin
Engineered Materials	253			27.8	%		706			26.0	%		148			20.9	%		170			24.9	%		195			28.6	%		193			29.9	%
Acetate Tow	51			40.8	%		246			47.9	%		48			37.2	%		56			43.8	%		71			51.4	%		71			59.7	%
Acetyl Chain	546			35.5	%		2,020			37.2	%		579			39.2	%		561			37.7	%		557			39.5	%		323			30.6	%
Other Activities(2)	(37	)					(137	)					(30	)					(48	)					(42	)					(17	)
Total	813			32.0	%		2,835			33.2	%		745			32.7	%		739			32.6	%		781			35.5	%		570			31.7	%

___________________________
(1)	Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details.
(2)	Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 3 Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited
	Q1 '22					2021					Q4 '21					Q3 '21					Q2 '21					Q1 '21
				per share					per share					per share					per share					per share					per share
	(In $ millions, except per share data)
Earnings (loss) from continuing operations attributable to Celanese Corporation	502			4.61		1,912			17.06		528			4.83		519			4.67		542			4.81		323			2.83
Income tax provision (benefit)	112					330					27					102					116					85
Earnings (loss) from continuing operations before tax	614					2,242					555					621					658					408
Certain Items attributable to Celanese Corporation (Table 8)	65					139					77					(1	)				13					50
Refinancing and related expenses(1)	14					9					—					9					—					—
Adjusted earnings (loss) from continuing operations before tax	693					2,390					632					629					671					458
Income tax (provision) benefit on adjusted earnings(2)	(90	)				(359	)				(95	)				(94	)				(105	)				(64	)
Adjusted earnings (loss) from continuing operations(3)	603			5.54		2,031			18.12		537			4.91		535			4.82		566			5.02		394			3.46
	Diluted shares (in millions)(4)
Weighted average shares outstanding	108.2					111.2					108.6					110.5					112.3					113.5
Incremental shares attributable to equity awards	0.7					0.9					0.8					0.5					0.5					0.5
Total diluted shares	108.9					112.1					109.4					111.0					112.8					114.0

______________________________
(1)	Includes $14 million of interest expense for fees related to a bridge facility commitment letter for our acquisition of a majority of the Mobility & Materials business of DuPont de Nemours, Inc.
(2)	Calculated using adjusted effective tax rates (Table 3a) as follows:

	Q1 '22					2021					Q4 '21					Q3 '21					Q2 '21					Q1 '21
Adjusted effective tax rate	13					15					15					15					16					14

(3)	Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns.

		Actual Plan Asset Returns		Expected Plan Asset Returns
		(In percentages)
2021		1.1		6.3

(4)	Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive.

Table 3a Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited
	Estimated			Actual
	2022			2021
	(In percentages)
US GAAP annual effective tax rate	17			15
Discrete quarterly recognition of GAAP items(1)	(1	)		(2	)
Tax impact of other charges and adjustments(2)	(3	)		(1	)
Utilization of foreign tax credits	—			(1	)
Changes in valuation allowances, excluding impact of other charges and adjustments(3)	—			3
Other(4)	—			1
Adjusted tax rate	13			15

______________________________
Note: As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate for actual results.
(1)	Such as changes in tax laws (including US tax reform), deferred taxes on outside basis differences, changes in uncertain tax positions and prior year audit adjustments.
(2)	Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes.
(3)	Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments.
(4)	Tax impacts related to full-year forecasted tax opportunities and related costs.

Table 4 Net Sales by Segment - Unaudited
	Q1 '22			2021			Q4 '21			Q3 '21			Q2 '21			Q1 '21
	(In $ millions)
Engineered Materials	910			2,718			707			684			682			645
Acetate Tow	125			514			129			128			138			119
Acetyl Chain	1,538			5,430			1,476			1,489			1,409			1,056
Other Activities	—			—			—			—			—			—
Intersegment eliminations(1)	(35	)		(125	)		(37	)		(35	)		(31	)		(22	)
Net sales	2,538			8,537			2,275			2,266			2,198			1,798

___________________________
(1)	Includes intersegment sales primarily related to the Acetyl Chain.

Table 4a Factors Affecting Segment Net Sales Sequentially - Unaudited   Three Months Ended March 31, 2022 Compared to Three Months Ended December 31, 2021
	Volume			Price			Currency			Other		Total
	(In percentages)
Engineered Materials	23			7			(1	)		—		29
Acetate Tow	(6	)		3			—			—		(3	)
Acetyl Chain	8			(3	)		(1	)		—		4
Total Company	12			1			(1	)		—		12

Three Months Ended December 31, 2021 Compared to Three Months Ended September 30, 2021
	Volume			Price			Currency			Other		Total
	(In percentages)
Engineered Materials	(1	)		5			(1	)		—		3	(1)
Acetate Tow	—			1			—			—		1
Acetyl Chain	(10	)		10			(1	)		—		(1	)
Total Company	(7	)		8			(1	)		—		—

Three Months Ended September 30, 2021 Compared to Three Months Ended June 30, 2021
	Volume			Price			Currency			Other		Total
	(In percentages)
Engineered Materials	(2	)		3			(1	)		—		—
Acetate Tow	(8	)		—			—			—		(8	)
Acetyl Chain	3			3			—			—		6
Total Company	1			3			(1	)		—		3

Three Months Ended June 30, 2021 Compared to Three Months Ended March 31, 2021
	Volume			Price			Currency			Other		Total
	(In percentages)
Engineered Materials	(1	)		7			—			—		6
Acetate Tow	16			—			—			—		16
Acetyl Chain	7			27			—			—		34
Total Company	4			18			—			—		22

Three Months Ended March 31, 2021 Compared to Three Months Ended December 31, 2020
	Volume			Price			Currency			Other		Total
	(In percentages)
Engineered Materials	6			6			1			—		13
Acetate Tow	(10	)		(1	)		—			—		(11	)
Acetyl Chain	(7	)		23			—			—		16
Total Company	(3	)		15			1			—		13

________________________
(1)	2021 includes the effect of the acquisition of the Santoprene™ thermoplastic vulcanizates elastomers business.

Table 4b Factors Affecting Segment Net Sales Year Over Year - Unaudited   Three Months Ended March 31, 2022 Compared to Three Months Ended March 31, 2021
	Volume			Price			Currency			Other			Total
	(In percentages)
Engineered Materials	20			25			(4	)		—			41
Acetate Tow	1			4			—			—			5
Acetyl Chain	8			39			(1	)		—			46
Total Company	12			32			(2	)		(1	)		41

Three Months Ended December 31, 2021 Compared to Three Months Ended December 31, 2020
	Volume			Price			Currency			Other			Total
	(In percentages)
Engineered Materials	5			20			(1	)		—			24
Acetate Tow	(3	)		(1	)		—			—			(4	)
Acetyl Chain	(6	)		68			—			—			62
Total Company	(2	)		46			(1	)		—			43

Three Months Ended September 30, 2021 Compared to Three Months Ended September 30, 2020
	Volume			Price			Currency			Other			Total
	(In percentages)
Engineered Materials	11			17			2			—			30
Acetate Tow	—			(2	)		—			1			(1	)
Acetyl Chain	11			80			1			—			92
Total Company	10			50			1			—			61

Three Months Ended June 30, 2021 Compared to Three Months Ended June 30, 2020
	Volume			Price			Currency			Other			Total
	(In percentages)
Engineered Materials	43			11			8			—			62
Acetate Tow	10			(1	)		—			—			9
Acetyl Chain	27			83			3			—			113
Total Company	31			50			4			(1	)		84

Three Months Ended March 31, 2021 Compared to Three Months Ended March 31, 2020
	Volume			Price			Currency			Other			Total
	(In percentages)
Engineered Materials	7			2			6			—			15
Acetate Tow	(8	)		—			—			—			(8	)
Acetyl Chain	5			25			2			—			32
Total Company	5			14			4			—			23

Table 4c Factors Affecting Segment Net Sales Year Over Year - Unaudited   Year Ended December 31, 2021 Compared to Year Ended December 31, 2020
	Volume			Price			Currency			Other			Total
	(In percentages)
Engineered Materials	15			12			4			—			31
Acetate Tow	—			(1	)		—			—			(1	)
Acetyl Chain	9			62			2			—			73
Total Company	10			39			2			—			51

Table 5 Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited
	Q1 '22			2021			Q4 '21			Q3 '21			Q2 '21			Q1 '21
	(In $ millions, except percentages)
Net cash provided by (used in) investing activities	(149	)		(1,119	)		(1,286	)		(108	)		177			98
Net cash provided by (used in) financing activities	(95	)		(1,042	)		(99	)		(228	)		(344	)		(371	)
Net cash provided by (used in) operating activities	316			1,757			584			630			427			116
Capital expenditures on property, plant and equipment	(137	)		(467	)		(163	)		(102	)		(110	)		(92	)
Distributions to NCI	(4	)		(27	)		(6	)		(8	)		(8	)		(5	)
Free cash flow(1)(2)	175			1,263			415			520			309			19
Net sales	2,538			8,537			2,275			2,266			2,198			1,798
Free cash flow as % of Net sales	6.9	%		14.8	%		18.2	%		22.9	%		14.1	%		1.1	%

______________________________
(1)	Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for capital contributions or distributions to Mitsui related to our joint venture, Fairway.
(2)	Excludes required debt service and finance lease payments of $25 million and $30 million for the years ended December 31, 2022 and 2021, respectively.

Table 6 Cash Dividends Received - Unaudited
	Q1 '22			2021			Q4 '21			Q3 '21			Q2 '21			Q1 '21
	(In $ millions)
Dividends from equity method investments	26			112			51			8			18			35
Dividends from equity investments without readily determinable fair values	37			147			33			35			37			42
Total	63			259			84			43			55			77

Table 7 Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited
	Q1 '22			2021			Q4 '21			Q3 '21			Q2 '21			Q1 '21
	(In $ millions)
Short-term borrowings and current installments of long-term debt - third party and affiliates	860			791			791			103			500			497
Long-term debt, net of unamortized deferred financing costs	3,132			3,176			3,176			3,724			3,156			3,135
Total debt	3,992			3,967			3,967			3,827			3,656			3,632
Cash and cash equivalents	(605	)		(536	)		(536	)		(1,340	)		(1,054	)		(791	)
Net debt	3,387			3,431			3,431			2,487			2,602			2,841

Table 8 Certain Items - Unaudited The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures:
	Q1 '22		2021			Q4 '21		Q3 '21			Q2 '21		Q1 '21			Income Statement Classification
	(In $ millions)
Exit and shutdown costs	7		18			8		7			5		(2	)		Cost of sales / SG&A / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net / Non-operating pension and other postretirement employee benefit (expense) income
Asset impairments	—		2			—		—			1		1			Cost of sales / Other (charges) gains, net
Impact from plant incidents and natural disasters(1)	—		41			—		—			—		41			Cost of sales
Mergers, acquisitions and dispositions	56		29			19		4			6		—			Cost of sales / SG&A
Actuarial (gain) loss on pension and postretirement plans	—		43			43		—			—		—			Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income
Legal settlements and commercial disputes	2		16			4		2			1		9			Cost of sales / SG&A / Other (charges) gains, net
Other	—		(10	)		3		(14	)(2)		—		1			Cost of sales / SG&A / Gain (loss) on disposition of businesses and assets, net
Certain Items attributable to Celanese Corporation	65		139			77		(1	)		13		50

___________________________
(1)	Primarily associated with Winter Storm Uri.
(2)	Primarily associated with the sale of our Spondon site.

Table 9 Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited
					2021
					(In $ millions, except percentages)
Net earnings (loss) attributable to Celanese Corporation					1,890
Adjusted EBIT (Table 1)					2,473
Adjusted effective tax rate (Table 3a)					15	%
Adjusted EBIT tax effected					2,102
	2021		2020		Average
	(In $ millions, except percentages)
Short-term borrowings and current installments of long-term debt - third parties and affiliates	791		496		644
Long-term debt, net of unamortized deferred financing costs	3,176		3,227		3,202
Celanese Corporation stockholders' equity	4,189		3,526		3,858
Invested capital					7,704
Return on invested capital (adjusted)					27.3	%
Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital					24.5	%

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20220427005831/en/

Investor Relations
Brandon Ayache
Phone: +1 972 443 8509
brandon.ayache@celanese.com

Media - U.S.
Travis Jacobsen
Phone: +1 972 443 3750
william.jacobsen@celanese.com

Media - Europe
Petra Czugler
Phone: +49 69 45009 1206
petra.czugler@celanese.com

Source: Celanese Corporation